An open label, dose-escalating study of safety & tolerability of cannabidiol in 13 individuals with Parkinsons; CBD "may be efficacious in PD, but the relatively high dose used in this study was associated with liver enzyme elevations
Safety and Tolerability of Cannabidiol in... - Cure Parkinson's
Safety and Tolerability of Cannabidiol in Parkinson Disease: An Open Label, Dose-Escalation Study
![Farooqji profile image](https://images.hu-production.be/avatars/d2bcede6695608a9d172b4c00f6b376c_small@2x_100x100.jpg)
Written by
![Farooqji profile image](https://images.hu-production.be/avatars/d2bcede6695608a9d172b4c00f6b376c_small@2x_100x100.jpg)
Farooqji
To view profiles and participate in discussions please or .
Read more about...
Not what you're looking for?
You may also like...
Medium-Dose Lithium May Hit Parkinson Disease Targets...
it may be unnecessarily negative. Here is the article: Medium-Dose Lithium May Hit Parkinson...
The Effect of Curcumin on Idiopathic Parkinson Disease: A Clinical and Skin Biopsy Study
Curcumin on Idiopathic Parkinson Disease: A Clinical and Skin Biopsy Study 2022...
The Effect of Curcumin on Idiopathic Parkinson Disease: A Clinical and Skin Biopsy Study
therapies for Parkinson disease (PD). Curcumin shows anti-amyloidogenic properties in vitro and may...
early-initiation-of-low-dose-levodopa-fails-to-arrest-parkinsons-disease-progression
https://medicaldialogues.in/neurology-neurosurgery/news/early-initiation-of-low-dose-levodopa-fails-
Free Webinar: “Zhittya's Parkinson's Disease Research Study: 6-Month Patient Follow-Up Report”
the status of the first Parkinson's disease patients dosed with FGF-1 back in May 2022. Data will...